202 related articles for article (PubMed ID: 34425109)
1. Structural and functional characterization of ubiquitin variant inhibitors for the JAMM-family deubiquitinases STAMBP and STAMBPL1.
Guo Y; Liu Q; Mallette E; Caba C; Hou F; Fux J; LaPlante G; Dong A; Zhang Q; Zheng H; Tong Y; Zhang W
J Biol Chem; 2021 Oct; 297(4):101107. PubMed ID: 34425109
[TBL] [Abstract][Full Text] [Related]
2. Generation and Validation of Intracellular Ubiquitin Variant Inhibitors for USP7 and USP10.
Zhang W; Sartori MA; Makhnevych T; Federowicz KE; Dong X; Liu L; Nim S; Dong A; Yang J; Li Y; Haddad D; Ernst A; Heerding D; Tong Y; Moffat J; Sidhu SS
J Mol Biol; 2017 Nov; 429(22):3546-3560. PubMed ID: 28587923
[TBL] [Abstract][Full Text] [Related]
3. Plant deubiquitinases: from structure and activity to biological functions.
Luo R; Yang K; Xiao W
Plant Cell Rep; 2023 Mar; 42(3):469-486. PubMed ID: 36567335
[TBL] [Abstract][Full Text] [Related]
4. On the Study of Deubiquitinases: Using the Right Tools for the Job.
Caba C; Mohammadzadeh A; Tong Y
Biomolecules; 2022 May; 12(5):. PubMed ID: 35625630
[TBL] [Abstract][Full Text] [Related]
5. Development of Ubiquitin Variants with Selectivity for Ubiquitin C-Terminal Hydrolase Deubiquitinases.
Hewitt CS; Krabill AD; Das C; Flaherty DP
Biochemistry; 2020 Sep; 59(37):3447-3462. PubMed ID: 32865982
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional characterization of a ubiquitin variant engineered for tight and specific binding to an alpha-helical ubiquitin interacting motif.
Manczyk N; Yates BP; Veggiani G; Ernst A; Sicheri F; Sidhu SS
Protein Sci; 2017 May; 26(5):1060-1069. PubMed ID: 28276594
[TBL] [Abstract][Full Text] [Related]
7. Yeast Two-Hybrid Analysis for Ubiquitin Variant Inhibitors of Human Deubiquitinases.
Pascoe N; Seetharaman A; Teyra J; Manczyk N; Satori MA; Tjandra D; Makhnevych T; Schwerdtfeger C; Brasher BB; Moffat J; Costanzo M; Boone C; Sicheri F; Sidhu SS
J Mol Biol; 2019 Mar; 431(6):1160-1171. PubMed ID: 30763569
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori-induced reactive oxygen species direct turnover of CSN-associated STAMBPL1 and augment apoptotic cell death.
Chaithongyot S; Naumann M
Cell Mol Life Sci; 2022 Jan; 79(2):86. PubMed ID: 35066747
[TBL] [Abstract][Full Text] [Related]
9. A strategy for modulation of enzymes in the ubiquitin system.
Ernst A; Avvakumov G; Tong J; Fan Y; Zhao Y; Alberts P; Persaud A; Walker JR; Neculai AM; Neculai D; Vorobyov A; Garg P; Beatty L; Chan PK; Juang YC; Landry MC; Yeh C; Zeqiraj E; Karamboulas K; Allali-Hassani A; Vedadi M; Tyers M; Moffat J; Sicheri F; Pelletier L; Durocher D; Raught B; Rotin D; Yang J; Moran MF; Dhe-Paganon S; Sidhu SS
Science; 2013 Feb; 339(6119):590-5. PubMed ID: 23287719
[TBL] [Abstract][Full Text] [Related]
10. Regulation of proteolysis by human deubiquitinating enzymes.
Eletr ZM; Wilkinson KD
Biochim Biophys Acta; 2014 Jan; 1843(1):114-28. PubMed ID: 23845989
[TBL] [Abstract][Full Text] [Related]
11. Cellular Assays for Dynamic Quantification of Deubiquitinase Activity and Inhibition.
Moghadasi SA; Moraes SN; Harris RS
J Mol Biol; 2023 Dec; 435(23):168316. PubMed ID: 37858708
[TBL] [Abstract][Full Text] [Related]
12. Saturation scanning of ubiquitin variants reveals a common hot spot for binding to USP2 and USP21.
Leung I; Dekel A; Shifman JM; Sidhu SS
Proc Natl Acad Sci U S A; 2016 Aug; 113(31):8705-10. PubMed ID: 27436899
[TBL] [Abstract][Full Text] [Related]
13. A Panel of Engineered Ubiquitin Variants Targeting the Family of Domains Found in Ubiquitin Specific Proteases (DUSPs).
Tang JQ; Veggiani G; Singer A; Teyra J; Chung J; Sidhu SS
J Mol Biol; 2021 Dec; 433(24):167300. PubMed ID: 34666042
[TBL] [Abstract][Full Text] [Related]
14. Identification and Characterization of Mutations in Ubiquitin Required for Non-covalent Dimer Formation.
Gabrielsen M; Buetow L; Kowalczyk D; Zhang W; Sidhu SS; Huang DT
Structure; 2019 Sep; 27(9):1452-1459.e4. PubMed ID: 31303481
[TBL] [Abstract][Full Text] [Related]
15. Development of an OTUD1 ubiquitin variant inhibitor.
Liu Q; Mallette E; Zheng H; Zhang W
Biochem J; 2023 Aug; 480(16):1317-1330. PubMed ID: 37589489
[TBL] [Abstract][Full Text] [Related]
16. Dimerization of a ubiquitin variant leads to high affinity interactions with a ubiquitin interacting motif.
Manczyk N; Veggiani G; Gish GD; Yates BP; Ernst A; Sidhu SS; Sicheri F
Protein Sci; 2019 May; 28(5):848-856. PubMed ID: 30793400
[TBL] [Abstract][Full Text] [Related]
17. The deubiquitinating enzyme STAMBP is a newly discovered driver of triple-negative breast cancer progression that maintains RAI14 protein stability.
Yang Q; Yan D; Zou C; Xue Q; Lin S; Huang Q; Li X; Tang D; Chen X; Liu J
Exp Mol Med; 2022 Nov; 54(11):2047-2059. PubMed ID: 36434041
[TBL] [Abstract][Full Text] [Related]
18. Structural Insight into Ubiquitin-Like Protein Recognition and Oligomeric States of JAMM/MPN
Cao S; Engilberge S; Girard E; Gabel F; Franzetti B; Maupin-Furlow JA
Structure; 2017 Jun; 25(6):823-833.e6. PubMed ID: 28479062
[TBL] [Abstract][Full Text] [Related]
19. Rational Development and Characterization of a Ubiquitin Variant with Selectivity for Ubiquitin C-Terminal Hydrolase L3.
Hewitt CS; Das C; Flaherty DP
Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053210
[TBL] [Abstract][Full Text] [Related]
20. Structural and Functional Analysis of Ubiquitin-based Inhibitors That Target the Backsides of E2 Enzymes.
Garg P; Ceccarelli DF; Keszei AFA; Kurinov I; Sicheri F; Sidhu SS
J Mol Biol; 2020 Feb; 432(4):952-966. PubMed ID: 31634471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
